Pulmonary disease
Conditions
Interventions
Group A:Muscle relaxants are not administered during anesthesia induction
Group B:Muscle relaxants were given during anesthesia induction
Sponsors
The First Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients undergoing elective electronic bronchoscopic interventional surgery; 2. Age 18 years or older; 3. Modified Mallampati Classification Class I or II; 4. American Society of Anesthesiologists (ASA) I-III; 5. The duration of bronchoscopic surgery >=20min; 6. Through pre-anesthesia assessment, the patient/family member has informed consent and signed the consent form; 7. The general clinical information of the patient is complete.
Exclusion criteria
Exclusion criteria: 1. Patients with predictable difficult airway; 2. Previous trauma, burns, etc., with small mouth opening (<2 transverse fingers); 3. Combined with severe cardiovascular disease, abnormal liver and kidney function; 4. Morbidly obese patients with body mass index (BMI) greater than 35kg/m^2; 5. Have a history of severe gastroesophageal reflux in the past, and have recent signs of seizures; 6. High risk of reflux aspiration; 7. Those who have a history of abnormal surgical anesthesia recovery in the past; 8. Patients with mental illness and previous allergies to conventional anesthetic drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of laryngeal spasm;The incidence of mirror choking;; | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction with laryngeal mask placement;The severity of post-operative sore throat;Dysphagia;Hoarse voice;Nausea;Vomit;NIBP;HR;Ppeak;Pplat;PetCO2;SpO2; | — |
Countries
China
Contacts
Public ContactLiu Shujie
The First Affiliated Hospital of Harbin Medical University
Outcome results
None listed